clear
Wednesday July 18th, 2018 6:26AM

Immune therapy scores big win against lung cancer in study

By The Associated Press

CHICAGO (AP) — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.

In the study, Merck's Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone after nearly one year. The results are expected to quickly set a new standard of care for about 70,000 patients each year in the United States whose lung cancer has already spread by the time it's found.

Another study found that an immunotherapy combo — the Bristol-Myers Squibb drugs Opdivo and Yervoy — worked better than chemo for delaying the time until cancer worsened in advanced lung cancer patients whose tumors have many gene flaws, as nearly half do. But the benefit lasted less than two months on average and it's too soon to know if the combo improves overall survival, as Keytruda did.

All of these immune therapy treatments worked for only about half of patients, but that's far better than chemo has done in the past.

"We're not nearly where we need to be yet," said Dr. Roy Herbst, a Yale Cancer Center lung expert who had no role in the studies.

Results were discussed Monday at an American Association for Cancer Research conference in Chicago and published by the New England Journal of Medicine. The studies were sponsored by the drugmakers, and many study leaders and Herbst consult for the companies.

ABOUT THE DRUGS

Keytruda, Yervoy and Opdivo are called checkpoint inhibitors. They remove a cloak that some cancer cells have that hides them from the immune system. The drugs are given through IVs and cost about $12,500 a month.

Keytruda was approved last year as an initial treatment with chemo for the most common form of advanced lung cancer, but doctors have been leery to use it because that was based on a small study that did not show whether it prolongs life.

The new study, led by Dr. Leena Gandhi of NYU's Perlmutter Cancer Center, gives that proof. In it, 616 patients were given chemo and some also received Keytruda. Those not given Keytruda were allowed to switch to it if their cancer worsened.

After one year, 69 percent of people originally assigned to Keytruda were alive versus 49 percent of the others — a result that experts called remarkable considering that the second group's survival was improved because half of them wound up switching.

How much it ultimately will extend life isn't known — more than half in the Keytruda group are still alive; median survival was just over 11 months for the others.

The Keytruda combo also delayed the time until cancer worsened — an average of nine months versus five months for the chemo-only group.

That's a big difference for such an advanced cancer, said Dr. Alice Shaw, a Massachusetts General Hospital lung cancer expert and one of the conference leaders. "This is really a pivotal study ... a new standard of care," said Shaw, who has no ties to the drugmakers.

Rates of serious side effects were similar, but twice as many in the Keytruda group dropped out because of them. More than 4 percent of that group developed lung inflammation and three patients died of it.

THE COMPETITION

Dr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center in New York led a study testing the Opdivo-Yervoy combo versus chemo in a slightly different group of newly diagnosed advanced lung cancer patients.

The study design was changed after it was underway to look at results according to patients' tumor mutation burden — a measure of how flawed their cancer genes are, according to a profiling test by Foundation Medicine. Medicare recently agreed to cover the $3,000 test for advanced cancers.

Of 679 patients, 299 had a high number of gene flaws in their tumors. In that group, survival without worsening of disease was 43 percent after one year for those on the immunotherapy drugs versus 13 percent of those on chemo. The immunotherapy drugs did not help people with fewer tumor gene flaws.

"We have a tool that helps us determine who are the patients that are most likely to benefit from this combination," Hellmann said.

The median time until cancer worsened was about 7 months on the immunotherapy drugs versus 5.5 months for chemo. Serious side effects were a little more common in the chemo group.

Another rival, Genentech, recently announced that its checkpoint inhibitor, Tecentriq, improved survival in a study similar to the one testing Keytruda. Details are expected in a couple months.

___

Marilynn Marchione can be followed on Twitter: @MMarchioneAP

___

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Health, AP Business
© Copyright 2018 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Trump seeks to limit access to records seized in FBI raid
President Donald Trump's personal attorney is set to appear in federal court to argue over evidence found during an FBI raid, and porn star Stormy Daniels is expected to be in attendance
9:56AM ( 29 minutes ago )
Bill Cosby lawyer scours accuser's words, looking for doubt
Bill Cosby's chief accuser is back on the witness stand as the comedian's lawyers look to raise doubts about her allegations that he drugged and molested her in 2004
9:39AM ( 47 minutes ago )
7 inmates dead, 17 injured in South Carolina prison fighting
South Carolina prisons spokesman: 7 inmates dead, 17 others injured amid fights at maximum security prison.
9:30AM ( 55 minutes ago )
U.S. News
The Latest: Starbucks CEO hopes to meet with arrested men
The CEO of Starbucks is in Philadelphia, hoping to meet with the two black men were arrested after store employees called 911 to say they were trespassing
10:16AM ( 9 minutes ago )
Turkey's opposition protests state of emergency with sit-ins
Supporters of Turkey's main opposition party have staged sit-in demonstrations across Turkey to protest the state of emergency that was declared after a coup attempt in 2016
10:13AM ( 12 minutes ago )
'Full Metal Jacket' actor R. Lee Ermey dies at 74
R. Lee Ermey, a former Marine who made a career in Hollywood playing hard-nosed military men like Gunnery Sergeant Hartman in Stanley Kubrick's "Full Metal Jacket," has died
10:12AM ( 13 minutes ago )
Associated Press (AP)
The Latest: Top women start wet, windy Boston Marathon
The top women are off at the Boston Marathon
9:47AM ( 38 minutes ago )
The Latest: Greek protesters target Truman statue
Members of a communist student organization have attempted to pull down a statue of U.S. President Harry Truman during an anti-war protest in central Athens
9:17AM ( 1 hour ago )
The Latest: Scathing Comey interview provokes Trump
Scathing Comey interview provokes Trump the morning after
9:12AM ( 1 hour ago )
AP National News
Opposition to immigrant sanctuary spreading in California
A growing number of cities and counties are resisting California's efforts to resist the Trump administration's crackdown on immigration, creating a patchwork of positions on how and when local police should help federal deportation agents
1:28AM ( 8 hours ago )
Judge to hear evidence in eccentric heir's murder case
Three years after the arrest of New York real estate heir Robert Durst in the fatal shooting of his best friend in Los Angeles there's still no trial scheduled
1:20AM ( 9 hours ago )
Will case of Dead Sea Scrolls, online aliases end with jail?
The unusual case of a New York man convicted of using online aliases to discredit his father's detractors in a debate over the Dead Sea Scrolls is coming to an end after nine years
10:49PM ( 11 hours ago )
Top U.S. News short headlines
Vatican: Parents, hospital must talk in UK sick toddler case
The head of the Vatican's bioethics think tank says he hopes a dialogue can be reopened in the case of Alfie Evans, a terminally ill British child whose parents are locked in a legal battle over his care
9:25AM ( 1 day ago )
Russians protest garbage dumps blighting Moscow region
Large protests have taken place in nine cities and towns in the Moscow region over pollution from landfills and against plans to build a garbage incinerator
1:24PM ( 1 day ago )
AP investigation: Doctors keep licenses despite sex abuse
An Associated Press investigation finds that even as Hollywood moguls, elite journalists and politicians have been pushed out of their jobs or resigned amid allegations of sexual misconduct, the world of medicine is more forgiving.
10:53AM ( 1 day ago )
AP Health
Liz Weston: Beat the retiree crowds to these 5 places abroad
Retiring in less popular places could mean a lower cost of living and a more authentic experience abroad
9:45AM ( 41 minutes ago )
Korean Air suspends 'nut rage' sister from work over tantrum
Korean Air Lines says it has suspended one of its chairman's daughters from work after she threw a tantrum at a business meeting, triggering a police investigation and public outrage
8:23AM ( 2 hours ago )
Allegiant Air under fire after '60 Minutes' safety report
Allegiant Air is under fire following a "60 Minutes" investigation that is raising significant safety concerns.
8:02AM ( 2 hours ago )
AP Business
Trump seeks to limit access to records seized in FBI raid
President Donald Trump's personal attorney is set to appear in federal court to argue over evidence found during an FBI raid, and porn star Stormy Daniels is expected to be in attendance
9:56AM ( 29 minutes ago )
Bill Cosby lawyer scours accuser's words, looking for doubt
Bill Cosby's chief accuser is back on the witness stand as the comedian's lawyers look to raise doubts about her allegations that he drugged and molested her in 2004
9:39AM ( 47 minutes ago )
7 inmates dead, 17 injured in South Carolina prison fighting
South Carolina prisons spokesman: 7 inmates dead, 17 others injured amid fights at maximum security prison.
9:30AM ( 55 minutes ago )
Stormy Daniels set for court as lawyers argue over FBI raid
President Donald Trump's personal attorney is set to appear in federal court to argue over evidence found during a recent FBI raid, and porn star Stormy Daniels is expected to be in attendance
9:10AM ( 1 hour ago )
Researchers mark death of Pearl Harbor mastermind Yamamoto
A group from the U.S. and Japan is trekking to a remote Pacific island to document the site where American fighters shot down a Japanese bomber carrying the mastermind of the Pearl Harbor attack
9:03AM ( 1 hour ago )